Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study-Reference-Cited by-同舟云学术

Comparison of Neoadjuvant Immunotherapy Plus Chemotherapy versus Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Study

Published:2023-08 Issue: Volume:Volume 16 Page:3351-3363
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Zhao Junfeng^ORCID,Hao Shaoyu,Tian Jing,Li Ying,Han Dan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference34 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline

3. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

4. Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

5. Clinical Challenges of Immune Checkpoint Inhibitors

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis;Journal of Evidence-Based Medicine;2024-08-19

2. Commentary: Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?;The Journal of Thoracic and Cardiovascular Surgery;2024-08

3. A computed tomography-based nomogram for neoadjuvant chemotherapy plus immunotherapy response prediction in patients with advanced esophageal squamous cell carcinoma;Frontiers in Oncology;2024-06-05

4. Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma;Frontiers in Immunology;2024-05-08